Intended Use

Brainomix 360 e-CTA is an image processing software package to be used by trained professionals to perform image viewing, processing, and analysis of CTA images.

Technology

Brainomix 360 e-CTA uses AI/ML algorithms to improve vessel detection by distinguishing bone from vessels and reducing image grain. It provides visualization with a 3D-colored overlay to show vessel density asymmetry between brain hemispheres. It connects with PACS and DICOM compliant devices, operating on standard off-the-shelf hardware or virtual servers.

Performance

Performance testing demonstrated that Brainomix 360 e-CTA accurately delineates vessels with high Dice Similarity Scores (~0.955) across 308 clinical CTA scans from diverse sources. AI/ML algorithm improvements reduced mean absolute error versus predicate device. Testing included phantom validation and retrospective clinical retrospective studies showing the device is safe, effective, and slightly improves performance relative to predicate.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    7/19/2024

    5 months
  • 2

    FDA Approval

    1/6/2025

Other devices from Brainomix Limited

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.